Resmed (RMD) Ratios
Resmed Ratios
MX:RMD's free cash flow for Q1 2027 was $373.68M. For the 2027 fiscal year, MX:RMD's free cash flow was decreased by $-48.74M and operating cash flow was $422.42M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.10 | 3.44 | 2.59 | 3.12 | 2.80 |
| Quick Ratio | 2.42 | 2.53 | 1.69 | 1.81 | 1.72 |
| Cash Ratio | 1.05 | 1.19 | 0.26 | 0.30 | 0.40 |
| Solvency Ratio | 0.74 | 0.74 | 0.62 | 0.42 | 0.56 |
| Operating Cash Flow Ratio | 1.29 | 1.72 | 1.54 | 0.91 | 0.51 |
| Short-Term Operating Cash Flow Coverage | 6.95 | 176.93 | 141.54 | 70.02 | 35.41 |
| Net Current Asset Value | $ 1.94B | $ 1.30B | $ 349.37M | $ -253.97M | $ 196.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.10 | 0.13 | 0.23 | 0.18 |
| Debt-to-Equity Ratio | 0.13 | 0.14 | 0.18 | 0.38 | 0.27 |
| Debt-to-Capital Ratio | 0.11 | 0.12 | 0.15 | 0.28 | 0.21 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.10 | 0.13 | 0.26 | 0.19 |
| Financial Leverage Ratio | 1.36 | 1.37 | 1.41 | 1.63 | 1.52 |
| Debt Service Coverage Ratio | 6.76 | 72.71 | 23.19 | 20.16 | 30.89 |
| Interest Coverage Ratio | 0.00 | 133.66 | 28.88 | 23.89 | 44.83 |
| Debt to Market Cap | 0.02 | 0.02 | 0.03 | 0.04 | 0.03 |
| Interest Debt Per Share | 5.71 | 5.89 | 6.26 | 11.09 | 6.43 |
| Net Debt to EBITDA | -0.30 | -0.19 | 0.41 | 1.00 | 0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.06% | 59.36% | 56.67% | 55.78% | 56.57% |
| EBIT Margin | 33.76% | 32.60% | 27.97% | 27.52% | 27.47% |
| EBITDA Margin | 38.08% | 37.18% | 32.73% | 32.18% | 32.88% |
| Operating Profit Margin | 33.76% | 32.75% | 28.17% | 26.80% | 27.96% |
| Pretax Profit Margin | 33.95% | 32.60% | 27.00% | 26.09% | 26.84% |
| Net Profit Margin | 26.94% | 27.22% | 21.79% | 21.25% | 21.78% |
| Continuous Operations Profit Margin | 26.94% | 27.22% | 21.79% | 21.25% | 21.78% |
| Net Income Per EBT | 79.36% | 83.50% | 80.72% | 81.47% | 81.15% |
| EBT Per EBIT | 100.57% | 99.54% | 95.83% | 97.33% | 96.02% |
| Return on Assets (ROA) | 16.99% | 17.14% | 14.86% | 13.29% | 15.30% |
| Return on Equity (ROE) | 23.13% | 23.47% | 20.99% | 21.73% | 23.19% |
| Return on Capital Employed (ROCE) | 25.21% | 23.55% | 22.14% | 18.89% | 22.70% |
| Return on Invested Capital (ROIC) | 19.27% | 19.56% | 17.77% | 15.31% | 18.29% |
| Return on Tangible Assets | 27.18% | 30.04% | 28.80% | 26.17% | 27.70% |
| Earnings Yield | 5.40% | 3.70% | 3.71% | 2.80% | 2.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.46 | 5.19 | 5.60 | 5.99 | 6.21 |
| Payables Turnover | 7.13 | 7.52 | 8.54 | 12.39 | 9.76 |
| Inventory Turnover | 2.33 | 2.25 | 2.47 | 1.87 | 2.09 |
| Fixed Asset Turnover | 7.69 | 7.16 | 6.70 | 6.34 | 5.68 |
| Asset Turnover | 0.63 | 0.63 | 0.68 | 0.63 | 0.70 |
| Working Capital Turnover Ratio | 2.09 | 2.62 | 3.07 | 2.96 | 3.76 |
| Cash Conversion Cycle | 172.48 | 183.63 | 170.33 | 226.54 | 196.09 |
| Days of Sales Outstanding | 66.90 | 70.26 | 65.23 | 60.93 | 58.75 |
| Days of Inventory Outstanding | 156.80 | 161.91 | 147.84 | 195.08 | 174.75 |
| Days of Payables Outstanding | 51.21 | 48.55 | 42.74 | 29.47 | 37.41 |
| Operating Cycle | 223.70 | 232.17 | 213.07 | 256.00 | 233.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 12.48 | 11.94 | 9.53 | 4.72 | 2.40 |
| Free Cash Flow Per Share | 11.40 | 11.33 | 8.75 | 3.81 | 1.34 |
| Dividend Paid and CapEx Coverage Ratio | 3.57 | 4.37 | 3.53 | 1.77 | 0.87 |
| Capital Expenditure Coverage Ratio | 11.55 | 19.49 | 12.20 | 5.17 | 2.25 |
| Operating Cash Flow Coverage Ratio | 2.19 | 2.06 | 1.60 | 0.44 | 0.38 |
| Operating Cash Flow to Sales Ratio | 0.32 | 0.34 | 0.30 | 0.16 | 0.10 |
| Free Cash Flow Yield | 5.85% | 4.39% | 4.68% | 1.74% | 0.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.67 | 27.02 | 26.92 | 35.73 | 39.28 |
| Price-to-Sales (P/S) Ratio | 4.99 | 7.36 | 5.87 | 7.59 | 8.56 |
| Price-to-Book (P/B) Ratio | 4.28 | 6.34 | 5.65 | 7.76 | 9.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.10 | 22.78 | 21.37 | 57.34 | 156.94 |
| Price-to-Operating Cash Flow Ratio | 15.62 | 21.61 | 19.61 | 46.25 | 87.20 |
| Price-to-Earnings Growth (PEG) Ratio | 2.00 | 0.72 | 2.01 | 2.45 | 0.62 |
| Enterprise Value Multiple | 12.80 | 19.60 | 18.34 | 24.60 | 26.57 |
| Enterprise Value | 27.56B | 37.50B | 28.12B | 33.42B | 31.26B |
| EV to EBITDA | 12.80 | 19.60 | 18.34 | 24.60 | 26.57 |
| EV to Sales | 4.87 | 7.29 | 6.00 | 7.91 | 8.74 |
| EV to Free Cash Flow | 16.71 | 22.56 | 21.86 | 59.75 | 160.24 |
| EV to Operating Cash Flow | 15.26 | 21.41 | 20.07 | 48.20 | 89.03 |
| Tangible Book Value Per Share | 22.27 | 16.74 | 10.45 | 5.50 | 7.38 |
| Shareholders’ Equity Per Share | 45.51 | 40.68 | 33.08 | 28.14 | 23.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.17 | 0.19 | 0.19 | 0.19 |
| Revenue Per Share | 39.07 | 35.08 | 31.87 | 28.77 | 24.50 |
| Net Income Per Share | 10.53 | 9.55 | 6.94 | 6.12 | 5.34 |
| Tax Burden | 0.79 | 0.83 | 0.81 | 0.81 | 0.81 |
| Interest Burden | 1.01 | 1.00 | 0.97 | 0.95 | 0.98 |
| Research & Development to Revenue | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 |
| SG&A to Revenue | 0.20 | 0.19 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 1.19 | 1.25 | 1.37 | 0.77 | 0.45 |
Currency in USD